Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer.
about
The ureteric bud epithelium: morphogenesis and roles in metanephric kidney patterning.Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease.Stromal protein Ecm1 regulates ureteric bud patterning and branching.EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast CancerGenetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.Role of Estrogens in the Size of Neuronal Somata of Paravaginal Ganglia in Ovariectomized Rabbits.Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer.Long-range transcriptional regulation of breast cancer genes.Expression variability and function of the RET gene in adult peripheral blood mononuclear cells.Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution.Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes.Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers.ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
P2860
Q30300352-B13555F7-564A-41E6-9C82-EBCE503AEBE5Q34720641-F6EDDC4C-C66F-4AFA-8F5D-0405BC5104B8Q35082847-CD9EFD35-A176-4324-BB04-3154FCBD4CA2Q36665258-14601024-AB28-47DE-8F8F-9CBA58F53BDBQ36940404-165786C5-7E2B-4538-83AD-66B8B6EC5F4FQ36970341-BC098ECC-90AD-4F81-99F4-9E7140B00D6DQ37214094-885F7A8F-8159-42CF-BF10-24254165FAFBQ37295706-ABC9908B-8755-4C7C-88C3-54E240E13ABAQ37683476-0BF18B77-9E74-405E-85B7-3E20B00260EFQ37701896-167AF72F-46D9-4C9D-B58E-B4AB60F68A9FQ37707145-1C7AC5F1-68D6-4F40-B4B8-5AC0609CEEB8Q38053130-BCF6950D-999A-49C3-A008-A6EE48E3CF02Q39000564-2FDFA23E-8884-4ACA-932D-DEDA34FF1B6AQ39013266-293136F8-E22B-42FE-9797-98139B84ADDBQ39137244-B99112FA-A0D5-4EA6-9F75-6F7BBC88844BQ47665602-2A028DA2-A7F5-45FB-B457-CD9BA4BFA153Q53699376-35B7E62F-EF32-4A8C-B502-B1FD8BE00782
P2860
Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Steroid hormone modulation of ...... ve enhancers in breast cancer.
@ast
Steroid hormone modulation of ...... ve enhancers in breast cancer.
@en
type
label
Steroid hormone modulation of ...... ve enhancers in breast cancer.
@ast
Steroid hormone modulation of ...... ve enhancers in breast cancer.
@en
prefLabel
Steroid hormone modulation of ...... ve enhancers in breast cancer.
@ast
Steroid hormone modulation of ...... ve enhancers in breast cancer.
@en
P2093
P2860
P356
P1476
Steroid hormone modulation of ...... ve enhancers in breast cancer.
@en
P2093
Andrew S McCallion
Seneca L Bessling
Shengchao Li
Zachary E Stine
P2860
P304
P356
10.1093/HMG/DDR291
P577
2011-07-07T00:00:00Z